Xeris Biopharma Holdings, Inc. Share Price
XERSXeris Biopharma Holdings, Inc. Stock Performance
Open $7.67 | Prev. Close $7.67 | Circuit Range N/A |
Day Range $7.62 - $7.84 | Year Range $4.52 - $10.07 | Volume 1,75,590 |
Average Traded $7.73 |
Xeris Biopharma Holdings, Inc. Share Price Chart
About Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Xeris Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Jun-26 | $7.67 | $7.75 | +0.00% |
29-Jun-26 | $7.67 | $7.75 | +1.31% |
26-Jun-26 | $7.51 | $7.65 | +3.24% |
25-Jun-26 | $7.50 | $7.41 | +0.14% |
24-Jun-26 | $7.32 | $7.40 | +2.64% |
23-Jun-26 | $6.95 | $7.21 | +4.64% |
22-Jun-26 | $7.01 | $6.89 | -0.86% |